www.vyvanse.com Open in urlscan Pro
2600:9000:224a:f000:12:7710:5640:93a1  Public Scan

Submitted URL: http://www.vyvanse.com/
Effective URL: https://www.vyvanse.com/
Submission: On January 02 via api from US — Scanned from DE

Form analysis 1 forms found in the DOM

/search-results

<form action="/search-results" class="searchbox">
  <label for="search-box" class="hidden-label">Search</label>
  <input id="search-box" type="search" placeholder="Search this site..." name="q">
  <span class="icon"></span>
</form>

Text Content

Vyvanse Label Update: Please see revised Important Safety Information below and
click for revised Medication Guide and Prescribing Information.

Vyvanse Program Update: Please click here for important information on Vyvanse.
If you have any other questions, please call 1‑877‑TAKEDA‑7 (1‑877‑825‑3327). 

Vyvanse Supply Notice: All strengths of Vyvanse are available at participating
wholesalers. Please check with your local pharmacy for availability.




Skip to content


For Moderate to Severe Binge Eating Disorder in Adults Medication Guide
Search
 * ADHD in Adults
   * What is ADHD?
   * Doctor Discussion Guide
   * How is ADHD Diagnosed?
 * About Vyvanse
   * What is Vyvanse?
   * Dosing & Administration
   * Study Results
   * Side Effects & Safety
 * Talking to your Doctor

 * Savings

 * Life with ADHD

 * ADHD in Children (Ages 6-17)

By prescription only.


VYVANSE IS THE #1 PRESCRIBED BRANDED ADHD MEDICATION


REDEFINE YOUR ADHD

ADHD shouldn’t define you. Learn more about treating
Attention-Deficit/Hyperactivity Disorder (ADHD) with Vyvanse (lisdexamfetamine
dimesylate). It all starts by having a conversation with your doctor and
exploring this site.

FOR ADHD IN ADULTS
FOR ADHD IN CHILDREN (AGES 6-17)
FOR MODERATE TO SEVERE B.E.D. IN ADULTS

B.E.D. = Binge Eating Disorder

Patient portrayal

+


V IS FOR VYVANSE


PROVEN TO HELP CONTROL
ADHD IN ADULTS

LEARN MORE ABOUT VYVANSE


*Vyvanse has been approved to treat ADHD in adults since 2008.


DO YOU RECOGNIZE
THE SYMPTOMS OF ADHD?

Learn about the core symptoms of ADHD: Inattention, Hyperactivity/Impulsivity.
If these sound familiar, consider talking to your doctor. Remember, only a
doctor or other healthcare provider can diagnose ADHD.


INATTENTION

PATIENT PORTRAYAL


HYPERACTIVITY/IMPULSIVITY

PATIENT PORTRAYAL

LEARN MORE ABOUT ADHD IN ADULTS
LEARN MORE ABOUT ADHD IN CHILDREN

Patient portrayal


A IS FOR IMPROVED ADHD SYMPTOMS

Vyvanse (lisdexamfetamine dimesylate) was shown to improve attention and reduce
hyperactivity and impulsivity in adults with ADHD.

LEARN MORE ABOUT VYVANSE


UPDATE ON
VYVANSE SAVINGS CARD PROGRAM

The Vyvanse Savings Card Program ends December 31, 2023. Vyvanse will continue
to be available by prescription. Check with your doctor and insurance plan for
more information.



Kabara, an adult patient diagnosed with moderate B.E.D.


BEFORE I WAS DIAGNOSED, I DIDN'T EVEN KNOW THAT B.E.D. EXISTED.”

Vyvanse is the first treatment for moderate to severe Binge EatingDisorder
(B.E.D.) in adults.

LEARN MORE


TALKING WITH YOUR DOCTOR

Information to help prepare you for a conversation with your doctor.

LEARN MORE


IMPORTANT SAFETY INFORMATION

Abuse, Misuse, and Addiction. VYVANSE has a high chance for abuse and misuse and
may lead to substance use problems, including addiction. Misuse and abuse of
VYVANSE, other amphetamine-containing medicines, and methylphenidate-containing
medicines, can lead to overdose and death. The risk of overdose and death is
increased with higher doses of VYVANSE or when it is used in ways that are not
approved, such as snorting or injection.  Your healthcare provider (HCP) should
check your or your child’s risk for abuse, misuse, and addiction before starting
treatment with VYVANSE and will monitor you or your child during treatment.
VYVANSE may lead to physical dependence after prolonged use, even if taken as
directed by your HCP. Do not give VYVANSE to anyone else. Keep VYVANSE in a safe
place and properly dispose of any unused medicine.

Tell your HCP if you or your child have ever abused or been dependent on
alcohol, prescription medicines, or street drugs.

Vyvanse is a federally controlled substance (CII) because it contains
lisdexamfetamine dimesylate that can be a target for people who abuse
prescription medicines or street drugs. Keep Vyvanse in a safe place to protect
it from theft. Never sell or give your Vyvanse to anyone else because it may
cause death or harm to them and it is against the law.


Who should not take Vyvanse?
Do not take Vyvanse if you or your child are:

 * allergic to amphetamine products or any of the ingredients in Vyvanse. See
   Medication Guide for a list of ingredients.
 * taking, or have stopped taking in the last 14 days, a medicine called a
   Monoamine Oxidase Inhibitor (MAOI).
 * being treated with the antibiotic linezolid or intravenous methylene blue.

Vyvanse may cause serious side effects, including:

 * Risks for people with serious heart disease. Sudden death has happened in
   people who have heart defects or other serious heart disease. Your HCP should
   check you or your child carefully for heart problems before starting
   treatment with Vyvanse. Tell your HCP if you or your child have any heart
   problems, heart disease, heart defects, or high blood pressure.  Call your
   HCP right away or go to the ER right away if you or your child have any signs
   of heart problems such as chest pain, shortness of breath, or fainting during
   treatment with Vyvanse.
 * Increased blood pressure and heart rate. Your healthcare provider should
   check your or your child’s blood pressure and heart rate regularly during
   treatment with Vyvanse.
 * Mental (psychiatric) problems, including: new or worse behavior and thought
   problems; new or worse bipolar illness; new psychotic symptoms (such as
   hearing voices, or seeing or believing things that are not real) or new manic
   symptoms. Tell your HCP about any mental problems you or your child have or
   about a family history of suicide, bipolar illness, or depression. Call your
   HCP right away if you or your child have any new or worsening mental symptoms
   or problems during treatment with Vyvanse, especially hearing voices, seeing
   or believing things that are not real, or new manic symptoms.
 * Slowing of growth (height and weight) in children. Children should have their
   height and weight checked often during treatment with Vyvanse. Vyvanse
   treatment may be stopped if your child is not growing or gaining weight.
 * Circulation problems in fingers and toes (Peripheral vasculopathy, including
   Raynaud’s phenomenon). Tell your HCP if your or your child’s fingers or toes
   feel numb, cool, painful, change color from pale, to blue, to red, or if they
   are sensitive to temperature. Call your HCP right away if you or your child
   have any signs of unexplained wounds appearing on fingers or toes during
   treatment with Vyvanse.
 * New or worsening tics or worsening Tourette’s syndrome. Tell your HCP if you
   or your child have or had repeated movements or sounds (tics) or Tourette’s
   syndrome, or have a family history of tics or Tourette’s syndrome. Tell your
   HCP if you or your child get any new or worsening tics or worsening
   Tourette’s syndrome during treatment with Vyvanse.
 * Serotonin Syndrome. A potentially life-threatening problem called serotonin
   syndrome may happen when Vyvanse is taken with certain other medicines. Stop
   taking Vyvanse and call your HCP or go to the nearest hospital ER right away
   if you or your child develop any of the following signs and symptoms of
   serotonin syndrome: agitation, flushing, coma, loss of coordination,
   dizziness, seeing or hearing things that are not real (hallucination), high
   body temperature (hyperthermia), fast heartbeat, seizures, sweating,
   confusion, tremors, stiff muscles, or muscle twitching, changes in blood
   pressure, nausea, vomiting, diarrhea.

Before taking Vyvanse, tell your HCP about all medical conditions, including if
you or your child:

 * have kidney problems.
 * are pregnant or plan to become pregnant. Vyvanse may harm the unborn baby.
 * are breastfeeding or plan to breastfeed. Vyvanse passes into breast milk. You
   or your child should not breastfeed during treatment with Vyvanse. Talk to
   your HCP about the best way to feed the baby during treatment with Vyvanse.

What are possible side effects of Vyvanse?
The most common side effects of Vyvanse in children 6 to 17 and adults with ADHD
include:

 * loss of appetite (anorexia)
 * decreased appetite 
 * diarrhea
 * dry mouth

 * trouble sleeping
 * stomach pain
 * anxiety
 * weight loss

 * dizziness
 * irritability
 * nausea
 * vomiting

The most common side effects of Vyvanse in adults with moderate to severe B.E.D.
include:

 * dry mouth
 * decreased appetite
 * constipation
 * anxiety

 * trouble sleeping
 * increased heart rate
 * feeling jittery

What is Vyvanse?
Vyvanse is a prescription medicine used for the treatment of
Attention-Deficit/Hyperactivity Disorder (ADHD) in patients 6 years and above,
and for the treatment of moderate to severe binge eating disorder (B.E.D.) in
adults. Vyvanse is not for use in children under 6 years of age with ADHD.
Vyvanse is not for weight loss. It is not known if Vyvanse is safe and effective
for the treatment of obesity. It is not known if Vyvanse is safe and effective
for use in children with B.E.D.

 

For additional safety information, click here for Prescribing
Information and Medication Guide and discuss with your HCP.

 

You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

 

Takeda is committed to helping ensure the proper use of stimulant medication.
Please see the Proper Use of Prescription Stimulant Medication for additional
information.

There is a pregnancy registry for females who are exposed to VYVANSE during
pregnancy. The purpose of the registry is to collect information about the
health of females exposed to VYVANSE and their baby. If you or your child
becomes pregnant during treatment with VYVANSE, talk to your healthcare provider
about registering with the National Pregnancy Registry for Psychostimulants at
1-866-961-2388 or visit online at
https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/adhd-medications/.



 * Medication Guide
 * Proper Use of Prescription Stimulant Medication
 * Prescribing Information
 * Takeda Patient Assistance Program
 * Privacy Notice
 * Contact Takeda

VYVANSE and the VYVANSE logo are registered trademarks of Takeda Pharmaceuticals
U.S.A., Inc. TAKEDA and the TAKEDA logo are registered trademarks of Takeda
Pharmaceutical Company Limited. ©2023 Takeda Pharmaceuticals U.S.A., Inc. All
rights reserved. 1-877-TAKEDA-7 (1-877-825-3327).

All content of this website, including text, images, graphics, sound files, and
their arrangement, is copyrighted and owned by Takeda Pharmaceuticals U.S.A.,
Inc. and is protected by international copyright laws. All other intellectual
property rights are reserved. The content may not be copied for commercial use
or distribution, nor may these objects be downloaded, modified, or posted to
other sites. This site is intended solely for US residents and is governed
solely by US laws and government regulations. Please see our Terms of Use for
more information. While Takeda makes reasonable efforts to include accurate,
up-to-date information on this site, Takeda makes no warranties or
representations as to its accuracy. Takeda assumes no liability for any errors
or omissions in the content of this site. The information on this site is not
intended to make a diagnosis or to take the place of talking to a US healthcare
professional.

US-LIS-1284v3.0 11/23


SCROLL FOR FULL MEDICATION GUIDE

×

MEDICATION GUIDE


VYVANSE® (VI'- VANS)

(lisdexamfetamine dimesylate)

Capsules and Chewable Tablets, CII

What is the most important information I should know about VYVANSE?

VYVANSE may cause serious side effects, including:

 * * Abuse, misuse, and addiction. VYVANSE has a high chance for abuse and
     misuse and may lead to substance use problems, including addiction. Misuse
     and abuse of VYVANSE, other amphetamine containing medicines, and
     methylphenidate containing medicines, can lead to overdose and death. The
     risk of overdose and death is increased with higher doses of VYVANSE or
     when it is used in ways that are not approved, such as snorting or
     injection.
   * Your healthcare provider should check you or your child’s risk for abuse,
     misuse, and addiction before starting treatment with VYVANSE and will
     monitor you or your child during treatment.
   * VYVANSE may lead to physical dependence after prolonged use, even if taken
     as directed by your healthcare provider.
   * Do not give VYVANSE to anyone else. See “What is VYVANSE?” for more
     information.
   * Keep VYVANSE in a safe place and properly dispose of any unused medicine.
     See "How should I store VYVANSE?" for more information.
   * Tell your healthcare provider if you or your child have ever abused or been
     dependent on alcohol, prescription medicines, or street drugs.
 * Risks for people with serious heart disease. Sudden death has happened in
   people who have heart defects or other serious heart disease.

Your healthcare provider should check you or your child carefully for heart
problems before starting treatment with VYVANSE. Tell your healthcare provider
if you or your child have any heart problems, heart disease, or heart defects.

Call your healthcare provider or go to the nearest hospital emergency room right
away if you or your child have any signs of heart problems such as chest pain,
shortness of breath, or fainting during treatment with VYVANSE.

 * Increased blood pressure and heart rate. Your healthcare provider should
   check you or your child’s blood pressure and heart rate regularly during
   treatment with VYVANSE.

 * Mental (psychiatric) problems, including:
   * new or worse behavior and thought problems
   * new or worse bipolar illness
   * new psychotic symptoms (such as hearing voices, or seeing or believing
     things that are not real) or new manic symptoms

Tell your healthcare provider about any mental problems you or your child have
or about a family history of suicide, bipolar illness, or depression.

Call your healthcare provider right away if you or your child have any new or
worsening mental symptoms or problems during treatment with VYVANSE, especially
hearing voices, seeing or believing things that are not real, or new manic
symptoms.

What Is VYVANSE?

VYVANSE is a central nervous system (CNS) stimulant prescription medicine used
for the treatment of:

 * Attention Deficit Hyperactivity Disorder (ADHD) in adults and children 6
   years of age and older. VYVANSE may help increase attention and decrease
   impulsiveness and hyperactivity in people with ADHD.
 * Moderate to severe binge eating disorder (BED) in adults. VYVANSE may help
   reduce the number of binge eating days in people with BED.

VYVANSE is not for use in children under 6 years of age with ADHD.

VYVANSE is not for weight loss. It is not known if VYVANSE is safe and effective
for the treatment of obesity.

It is not known if VYVANSE is safe and effective for use in children with BED.

VYVANSE is a federally controlled substance (CII) because it contains
lisdexamfetamine dimesylate that can be a target for people who abuse
prescription medicines or street drugs. Keep VYVANSE in a safe place to protect
it from theft. Never give your VYVANSE to anyone else because it may cause death
or harm them. Selling or giving away VYVANSE may harm others and is against the
law.

Do not take VYVANSE if you or your child are:

 * allergic to amphetamine products or any of the ingredients in VYVANSE. See
   the end of this Medication Guide for a complete list of ingredients in
   VYVANSE.
 * taking, or have stopped taking in the last 14 days, a medicine called a
   Monoamine Oxidase Inhibitor (MAOI).
 * being treated with the antibiotic linezolid or intravenous methylene blue.

Before taking VYVANSE, tell your healthcare provider about all medical
conditions, including if you or your child:

 * have heart problems, heart defects, or high blood pressure
 * have mental problems including psychosis, mania, bipolar illness, or
   depression or have a family history of suicide, bipolar illness, or
   depression
 * have circulation problems in fingers and toes
 * have kidney problems
 * have or had repeated movements or sounds (tics) or Tourette’s syndrome, or
   have a family history of tics or Tourette’s syndrome
 * are pregnant or plan to become pregnant. VYVANSE may harm the unborn baby.
   * There is a pregnancy registry for females who are exposed to VYVANSE during
     pregnancy. The purpose of the registry is to collect information about the
     health of females exposed to VYVANSE and their baby. If you or your child
     becomes pregnant during treatment with VYVANSE, talk to your healthcare
     provider about registering with the National Pregnancy Registry for
     Psychostimulants at 1-866-961-2388 or visit online
     at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/adhd-medications/.
 * are breastfeeding or plan to breastfeed. VYVANSE passes into breast milk. You
   should not breastfeed during treatment with VYVANSE. Talk to your healthcare
   provider about the best way to feed the baby during treatment with VYVANSE.

Tell your healthcare provider about all the medicines that you or your child
take, including prescription and over-the-counter medicines, vitamins, and
herbal supplements. 

VYVANSE can affect the way other medicines work and other medicines may affect
how VYVANSE works. Taking VYVANSE with other medicines can cause serious side
effects. Sometimes the doses of other medicines will need to be changed while
taking VYVANSE. 

Especially tell your healthcare provider if you or your child take: 

selective serotonin reuptake inhibitors (SSRIs) serotonin norepinephrine
reuptake inhibitors (SNRIs) medicines used to treat migraine headaches
called triptans tricyclic antidepressants lithium fentanyl tramadol tryptophan
buspirone St. John’s Wort


Keep a list of all medicines to show your healthcare provider and pharmacist
when you get a new medicine. Your healthcare provider will decide if VYVANSE can
be taken with other medicines.


Do not start any new medicine during treatment with VYVANSE without talking to
your healthcare provider first.

How should VYVANSE be taken?

 * Take VYVANSE exactly as prescribed by your healthcare provider.
 * Your healthcare provider may change the dose if needed.
 * Take VYVANSE 1 time each day in the morning with or without food.
 * VYVANSE comes in capsules or chewable tablets.

Taking VYVANSE Capsules:

 * VYVANSE capsules may be swallowed whole.
 * If VYVANSE capsules cannot be swallowed whole, the capsule may be opened and
   the entire contents sprinkled onto yogurt, or poured into water or orange
   juice.
   * Using a spoon, break apart any powder that is stuck together. Stir the
     VYVANSE powder and yogurt, water, or orange juice until they are completely
     mixed together.
   * Swallow all the yogurt, water, or orange juice mixture right away. Do
     not store the yogurt, water, or orange juice mixture.
   * It is normal to see a filmy coating on the inside of your glass or
     container after you eat or drink all the VYVANSE mixture.

Taking VYVANSE Chewable Tablets:

 * Chew VYVANSE tablets completely before swallowing.

If you or your child take too much VYVANSE, call your healthcare provider
or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency
room right away.

What are possible side effects of VYVANSE?

VYVANSE may cause serious side effects, including:

 * See "What is the most important information I should know about VYVANSE?"
 * Slowing of growth (height and weight) in children. Children should have their
   height and weight checked often during treatment with VYVANSE. VYVANSE
   treatment may be stopped if your child is not growing or gaining weight.
 * Circulation problems in fingers and toes (Peripheral vasculopathy, including
   Raynaud’s phenomenon). Signs and symptoms may include:
   * Fingers or toes may feel numb, cool, painful
   * Fingers or toes may change color from pale, to blue, to red

Tell your healthcare provider if you or your child have numbness, pain, skin
color change, or sensitivity to temperature in your fingers or toes.

Call your healthcare provider right away if you or your child have any signs of
unexplained wounds appearing on fingers or toes during treatment with VYVANSE.

 * New or worsening tics or worsening Tourette’s syndrome. Tell your healthcare
   provider if you or your child get any new or worsening tics or worsening
   Tourette’s syndrome during treatment with VYVANSE.
 * Serotonin Syndrome. A potentially life-threatening problem called serotonin
   syndrome may happen when VYVANSE is taken with certain other medicines. Stop
   taking VYVANSE and call your healthcare provider or go to the nearest
   hospital emergency room right away if you or your child develop any of the
   following signs and symptoms of serotonin syndrome:

agitation fast heartbeat flushing seizures coma sweating loss of coordination
confusion dizziness tremors, stiff muscles, or muscle twitching seeing or
hearing things that are not real (hallucination) changes in blood pressure high
body temperature (hyperthermia) nausea, vomiting, diarrhea

The most common side effects of VYVANSE in children 6 to 17 years old and adults
with ADHD include:

loss of appetite (anorexia) anxiety decreased appetite weight loss diarrhea
dizziness dry mouth  irritability trouble sleeping nausea stomach pain  vomiting

The most common side effects of VYVANSE in adults with BED include:

dry mouth trouble sleeping decreased appetite increased heart rate constipation
feeling jittery anxiety

These are not all the possible side effects of VYVANSE.

Call your doctor for medical advice about side effects. You may report side
effects to FDA at 1-800-FDA-1088.

How should I store VYVANSE?

 * Store VYVANSE in a safe place (like a locked cabinet) and in a tightly closed
   container at room temperature between 68°F to 77°F (20°C to 25°C).
 * Protect VYVANSE from light.
 * Dispose of remaining, unused, or expired VYVANSE by a medicine take-back
   program at a U.S. Drug Enforcement Administration (DEA) authorized collection
   site. If no take-back program or DEA authorized collector is available, mix
   VYVANSE with an undesirable, nontoxic substance such as dirt, cat litter, or
   used coffee grounds to make it less appealing to children and pets. Place the
   mixture in a container such as a sealed plastic bag and throw away VYVANSE in
   the household trash. Visit www.fda.gov/drugdisposal for additional
   information on disposal of unused medicines.

Keep VYVANSE and all medicines out of the reach of children.

General information about the safe and effective use of VYVANSE.

Medicines are sometimes prescribed for purposes other than those listed in a
Medication Guide. Do not use VYVANSE for a condition for which it was not
prescribed. Do not give VYVANSE to other people, even if they have the same
symptoms that you have. It may harm them and it is against the law. You can ask
your pharmacist or healthcare provider for information about VYVANSE that is
written for healthcare professionals.

What are the ingredients in VYVANSE?

Active Ingredient: lisdexamfetamine dimesylate

Capsule Inactive Ingredients: microcrystalline cellulose, croscarmellose sodium,
and magnesium stearate. The capsule shells (imprinted with S489) contain
gelatin, titanium dioxide, and one or more of the following: FD&C Red #3, FD&C
Yellow #6, FD&C Blue #1, Black Iron Oxide, and Yellow Iron Oxide.

Chewable Tablet Inactive ingredients: colloidal silicon dioxide, croscarmellose
sodium, guar gum, magnesium stearate, mannitol, microcrystalline cellulose,
sucralose, artificial strawberry flavor.

 

Distributed by: Takeda Pharmaceuticals America, Inc., Lexington, MA 02421.

VYVANSE® and the VYVANSE Logo® are registered trademarks of Takeda
Pharmaceuticals U.S.A., Inc.

©2023 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved.

For more information, go to www.vyvanse.com or call 1-877-TAKEDA-7
(1-877-825-3327).

This Medication Guide has been approved by the U.S. Food and Drug
Administration.

 

Revised: 10/2023
MG-0096 Reformatted for US-LIS-1284



CONTINUE TO THE SITE


IMPORTANT SAFETY INFORMATION

×

Abuse & Dependence. Vyvanse, other amphetamine containing medicines, and
methylphenidate have a high chance for abuse and may cause physical and
psychological dependence. Your healthcare provider (HCP) should check you or
your child for signs of abuse and dependence before and during treatment with
Vyvanse.

Tell your HCP if you or your child have ever abused or been dependent on
alcohol, prescription medicines, or street drugs. Your HCP can tell you more
about the differences between physical and psychological dependence and drug
addiction.

Vyvanse is a federally controlled substance (CII) because it contains
lisdexamfetamine dimesylate that can be a target for people who abuse
prescription medicines or street drugs. Keep Vyvanse in a safe place to protect
it from theft. Never sell or give your Vyvanse to anyone else because it may
cause death or harm to them and it is against the law.

 

Who should not take Vyvanse?
Do not take Vyvanse if you or your child are:

 * allergic to amphetamine products or any of the ingredients in Vyvanse. See
   Medication Guide for a list of ingredients.
 * taking, or have stopped taking in the last 14 days, a medicine called a
   Monoamine Oxidase Inhibitor (MAOI).
 * being treated with the antibiotic linezolid or intravenous methylene blue.

Vyvanse may cause serious side effects, including:

 * Heart-related problems including: sudden death, stroke, and heart attack in
   adults; sudden death in children who have heart problems or heart defects;
   increased blood pressure and heart rate. Your HCP should check you or your
   child carefully for heart problems before starting treatment with Vyvanse.
   Tell your HCP if you or your child have any heart problems, heart defects,
   high blood pressure, or a family history of these problems. Your HCP should
   check your or your child’s blood pressure and heart rate regularly during
   treatment with Vyvanse. Call your HCP or go to the ER right away if you or
   your child have any signs of heart problems such as chest pain, shortness of
   breath, or fainting during treatment with Vyvanse.
 * Mental (psychiatric) problems, including: new or worse behavior and thought
   problems; new or worse bipolar illness; new psychotic symptoms (such as
   hearing voices, or seeing or believing things that are not real) or new manic
   symptoms. Tell your HCP about any mental problems you or your child have or
   about a family history of suicide, bipolar illness, or depression. Call your
   HCP right away if you or your child have any new or worsening mental symptoms
   or problems during treatment with Vyvanse, especially hearing voices, seeing
   or believing things that are not real, or new manic symptoms.
 * Slowing of growth (height and weight) in children. Children should have their
   height and weight checked often during treatment with Vyvanse. Vyvanse
   treatment may be stopped if your child is not growing or gaining weight.
 * Circulation problems in fingers and toes (Peripheral vasculopathy, including
   Raynaud’s phenomenon). Tell your HCP if you or your child’s fingers or toes
   feel numb, cool, painful, change color from pale, to blue, to red, or if they
   are sensitive to temperature. Call your HCP right away if you or your child
   have any signs of unexplained wounds appearing on fingers or toes during
   treatment with Vyvanse.
 * Serotonin Syndrome. A potentially life-threatening problem called serotonin
   syndrome may happen when Vyvanse is taken with certain other medicines. Stop
   taking Vyvanse and call your HCP or go to the nearest hospital ER right away
   if you or your child develop any of the following signs and symptoms of
   serotonin syndrome: agitation, flushing, coma, loss of coordination,
   dizziness, seeing or hearing things that are not real (hallucination), high
   body temperature (hyperthermia), fast heartbeat, seizures, sweating,
   confusion, tremors, stiff muscles, or muscle twitching, changes in blood
   pressure, nausea, vomiting, diarrhea.

Before taking Vyvanse, tell your HCP about all medical conditions, including if
you or your child:
 * are pregnant or plan to become pregnant. Vyvanse may harm the unborn baby. 
 * are breastfeeding or plan to breastfeed. Vyvanse passes into breast milk. You
   or your child should not breastfeed during treatment with Vyvanse. Talk to
   your HCP about the best way to feed the baby during treatment with Vyvanse.

What are possible side effects of Vyvanse?
The most common side effects of Vyvanse in children 6 to 17 and adults with ADHD
include:

 * loss of appetite (anorexia)
 * decreased appetite
 * diarrhea
 * diarrhea

 * trouble sleeping
 * stomach pain
 * anxiety
 * weight loss

 * dizziness
 * irritability
 * nausea
 * vomiting

The most common side effects of Vyvanse in adults with moderate to severe B.E.D.
include:

 * dry mouth
 * decreased appetite
 * constipation
 * anxiety

 * trouble sleeping
 * increased heart rate
 * feeling jittery

What is Vyvanse?
Vyvanse is a prescription medicine used for the treatment of
Attention-Deficit/Hyperactivity Disorder (ADHD) in patients 6 years and above,
and for the treatment of moderate to severe binge eating disorder (B.E.D.) in
adults. Vyvanse is not for use in children under 6 years of age with ADHD.
Vyvanse is not for weight loss. It is not known if Vyvanse is safe and effective
for the treatment of obesity. It is not known if Vyvanse is safe and effective
for use in children with B.E.D.



For additional safety information, click here for Prescribing Information and
Medication Guide and discuss with your HCP.



You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.



Takeda is committed to helping ensure the proper use of stimulant medication.
Please see the Proper Use of Prescription Stimulant Medication for additional
information.




SCOLL FOR MORE IMPORTANT SAFETY INFORMATION. SEE THE MEDICATION GUIDE.

WHAT IS VYVANSE?

Vyvanse is for the treatment of ADHD in patients ≥6 years and for adults with
moderate to severe B.E.D. It is not for ADHD patients <6 years and not for
B.E.D. in patients <18 years. Vyvanse is not for weight loss or to treat
obesity.

MORE IMPORTANT SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

Abuse, Misuse, and Addiction. Vyvanse has a high chance for abuse and misuse and
may lead to substance use problems including addiction. Your healthcare provider
(HCP) should check your or your child’s risk for abuse, misuse, and addiction
before and during treatment. Vyvanse is a federally controlled substance (CII)
because it contains lisdexamfetamine dimesylate that can be a target for people
who abuse prescription medicines or street drugs. Keep Vyvanse in a safe place
to protect it from theft. Never sell or give your Vyvanse to anyone else because
it may cause death or harm to them and it is against the law. MORE IMPORTANT
SAFETY INFORMATION


Go Back


IMPORTANT SAFETY INFORMATION

Abuse, Misuse, and Addiction. VYVANSE has a high chance for abuse and misuse and
may lead to substance use problems, including addiction. Misuse and abuse of
VYVANSE, other amphetamine-containing medicines, and methylphenidate-containing
medicines, can lead to overdose and death. The risk of overdose and death is
increased with higher doses of VYVANSE or when it is used in ways that are not
approved, such as snorting or injection. Your healthcare provider (HCP) should
check your or your child’s risk for abuse, misuse, and addiction before starting
treatment with VYVANSE and will monitor you or your child during treatment.
VYVANSE may lead to physical dependence after prolonged use, even if taken as
directed by your HCP. Do not give VYVANSE to anyone else. Keep VYVANSE in a safe
place and properly dispose of any unused medicine.

Tell your HCP if you or your child have ever abused or been dependent on
alcohol, prescription medicines, or street drugs.

Vyvanse is a federally controlled substance (CII) because it contains
lisdexamfetamine dimesylate that can be a target for people who abuse
prescription medicines or street drugs. Keep Vyvanse in a safe place to protect
it from theft. Never sell or give your Vyvanse to anyone else because it may
cause death or harm to them and it is against the law.


Who should not take Vyvanse?
Do not take Vyvanse if you or your child are:

 * allergic to amphetamine products or any of the ingredients in Vyvanse. See
   Medication Guide for a list of ingredients.
 * taking, or have stopped taking in the last 14 days, a medicine called a
   Monoamine Oxidase Inhibitor (MAOI).
 * being treated with the antibiotic linezolid or intravenous methylene blue.

Vyvanse may cause serious side effects, including:

 * Risks for people with serious heart disease. Sudden death has happened in
   people who have heart defects or other serious heart disease. Your HCP should
   check you or your child carefully for heart problems before starting
   treatment with Vyvanse. Tell your HCP if you or your child have any heart
   problems, heart disease, heart defects, or high blood pressure.  Call your
   HCP right away or go to the ER right away if you or your child have any signs
   of heart problems such as chest pain, shortness of breath, or fainting during
   treatment with Vyvanse.
 * Increased blood pressure and heart rate. Your healthcare provider should
   check your or your child’s blood pressure and heart rate regularly during
   treatment with Vyvanse.
 * Mental (psychiatric) problems, including: new or worse behavior and thought
   problems; new or worse bipolar illness; new psychotic symptoms (such as
   hearing voices, or seeing or believing things that are not real) or new manic
   symptoms. Tell your HCP about any mental problems you or your child have or
   about a family history of suicide, bipolar illness, or depression. Call your
   HCP right away if you or your child have any new or worsening mental symptoms
   or problems during treatment with Vyvanse, especially hearing voices, seeing
   or believing things that are not real, or new manic symptoms.
 * Slowing of growth (height and weight) in children. Children should have their
   height and weight checked often during treatment with Vyvanse. Vyvanse
   treatment may be stopped if your child is not growing or gaining weight.
 * Circulation problems in fingers and toes (Peripheral vasculopathy, including
   Raynaud’s phenomenon). Tell your HCP if your or your child’s fingers or toes
   feel numb, cool, painful, change color from pale, to blue, to red, or if they
   are sensitive to temperature. Call your HCP right away if you or your child
   have any signs of unexplained wounds appearing on fingers or toes during
   treatment with Vyvanse.
 * New or worsening tics or worsening Tourette’s syndrome. Tell your HCP if you
   or your child have or had repeated movements or sounds (tics) or Tourette’s
   syndrome, or have a family history of tics or Tourette’s syndrome. Tell your
   HCP if you or your child get any new or worsening tics or worsening
   Tourette’s syndrome during treatment with Vyvanse.
 * Serotonin Syndrome. A potentially life-threatening problem called serotonin
   syndrome may happen when Vyvanse is taken with certain other medicines. Stop
   taking Vyvanse and call your HCP or go to the nearest hospital ER right away
   if you or your child develop any of the following signs and symptoms of
   serotonin syndrome: agitation, flushing, coma, loss of coordination,
   dizziness, seeing or hearing things that are not real (hallucination), high
   body temperature (hyperthermia), fast heartbeat, seizures, sweating,
   confusion, tremors, stiff muscles, or muscle twitching, changes in blood
   pressure, nausea, vomiting, diarrhea.

Before taking Vyvanse, tell your HCP about all medical conditions, including if
you or your child:

 * have kidney problems.
 * are pregnant or plan to become pregnant. Vyvanse may harm the unborn baby.
 * are breastfeeding or plan to breastfeed. Vyvanse passes into breast milk. You
   or your child should not breastfeed during treatment with Vyvanse. Talk to
   your HCP about the best way to feed the baby during treatment with Vyvanse.

What are possible side effects of Vyvanse?
The most common side effects of Vyvanse in children 6 to 17 and adults with ADHD
include:

 * loss of appetite (anorexia)
 * decreased appetite 
 * diarrhea
 * dry mouth

 * trouble sleeping
 * stomach pain
 * anxiety
 * weight loss

 * dizziness
 * irritability
 * nausea
 * vomiting

The most common side effects of Vyvanse in adults with moderate to severe B.E.D.
include:

 * dry mouth
 * decreased appetite
 * constipation
 * anxiety

 * trouble sleeping
 * increased heart rate
 * feeling jittery

What is Vyvanse?
Vyvanse is a prescription medicine used for the treatment of
Attention-Deficit/Hyperactivity Disorder (ADHD) in patients 6 years and above,
and for the treatment of moderate to severe binge eating disorder (B.E.D.) in
adults. Vyvanse is not for use in children under 6 years of age with ADHD.
Vyvanse is not for weight loss. It is not known if Vyvanse is safe and effective
for the treatment of obesity. It is not known if Vyvanse is safe and effective
for use in children with B.E.D.

 

For additional safety information, click here for Prescribing
Information and Medication Guide and discuss with your HCP.

 

You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

 

Takeda is committed to helping ensure the proper use of stimulant medication.
Please see the Proper Use of Prescription Stimulant Medication for additional
information.

There is a pregnancy registry for females who are exposed to VYVANSE during
pregnancy. The purpose of the registry is to collect information about the
health of females exposed to VYVANSE and their baby. If you or your child
becomes pregnant during treatment with VYVANSE, talk to your healthcare provider
about registering with the National Pregnancy Registry for Psychostimulants at
1-866-961-2388 or visit online at
https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/adhd-medications/.





YOU ARE ABOUT TO LEAVE
THIS TAKEDA WEBSITE

Takeda has no control over the content or presentation of the third-party site
you are about to view.

BACK CONTINUE


COOKIE PREFERENCE CENTER

When you visit our website, we store cookies on your browser to collect
information. The information collected might relate to you, your preferences or
your device, and is mostly used to make the site work as you expect it to and to
provide a more personalized web experience. However, you can choose not to allow
certain types of cookies, which may impact your experience of the site and the
services we are able to offer. Click on the different category headings to find
out more and change our default settings according to your preference. You
cannot opt-out of our First Party Strictly Necessary Cookies as they are
deployed in order to ensure the proper functioning of our website (such as
prompting the cookie banner and remembering your settings, to log into your
account, to redirect you when you log out, etc.).
More InformationLIMIT THE USE OF MY SENSITIVE PERSONAL INFORMATION
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms.    You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work. These cookies do not store any personally identifiable information.

View Vendor Details‎

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites.    They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

View Vendor Details‎

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site.    All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

View Vendor Details‎
Back Button


VENDORS LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Confirm My Choices